Form 4 Tracker
ARVINAS, INC.
ARVN

31 insider filings · Latest: Jun 24, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 22, 2026Sep 22 8:36 PMSUNIL AGARWAL
Proposed Sale
23,105$8.49$196.2K—

View →

Sep 9, 2026Sep 9 8:16 PMNOAH C BERKOWITZ
Proposed Sale
37,200$8.84$328.9K—

View →

Sep 4, 2026Sep 4 8:23 PMNOAH C BERKOWITZ
Proposed Sale
8,300$9.45$78.4K—

View →

Aug 4, 2026Aug 4 8:13 PMNOAH C BERKOWITZ
Proposed Sale
30,000$8.80$264.0K—

View →

Jul 9, 2026Jul 9 8:12 PMNOAH C BERKOWITZ
Proposed Sale
24,000$8.40$201.5K—

View →

Jun 24, 2026Jun 24 9:20 PMAndrew SaikChief Financial Officer
Sale
5,696$8.16$46.5K187,432(D)

View →

Jun 24, 2026Jun 23 10:09 PMAndrew Saik
Proposed Sale
5,846$8.14$47.6K—

View →

Jun 17, 2026Jun 18 8:06 PMAngela M CacaceChief Scientific Officer
Sale
2,576$7.60$19.6K180,390(D)

View →

Jun 17, 2026Jun 17 12:59 PMAngela Cacace
Proposed Sale
2,642$7.42$19.6K—

View →

May 21, 2026May 22 8:15 PMRandy TeelDirector, President and CEO
Sale
2,209$9.04$20.0K285,009(D)

View →

May 21, 2026May 20 9:34 PMRandy Teel
Proposed Sale
2,197$9.10$20.0K—

View →

May 11, 2026May 13 8:18 PMAndrew SaikChief Financial Officer
Sale
11,139$9.94$110.7K193,128(D)

View →

May 11, 2026May 13 8:17 PMDavid K LoomisVP, Chief Accounting Officer
Sale
1,919$9.94$19.1K40,193(D)

View →

May 11, 2026May 13 8:16 PMAngela M CacaceChief Scientific Officer
Sale
9,657$9.94$96.0K182,966(D)

View →

May 11, 2026May 13 8:16 PMBerkowitz NoahChief Medical Officer
Sale
11,108$9.94$110.4K191,395(D)

View →

May 11, 2026May 13 8:15 PMRandy TeelDirector, President and CEO
Sale
9,657$9.94$96.0K287,218(D)

View →

May 11, 2026May 8 10:06 PMAndrew Saik
Proposed Sale
11,343$10.11$114.7K—

View →

May 11, 2026May 8 10:06 PMAngela Cacace
Proposed Sale
9,834$10.11$99.4K—

View →

May 11, 2026May 8 10:05 PMNoah Berkowitz
Proposed Sale
11,312$10.11$114.4K—

View →

May 11, 2026May 8 10:05 PMRandy Teel
Proposed Sale
9,834$10.11$99.4K—

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 24, 2026Jun 26 8:23 PMAlsup Laurie SmaldoneDirector
Grant/Award
22,714$8.0522,714(D)

View →

Jun 24, 2026Jun 26 8:23 PMLeslie V NorwalkDirector
Grant/Award
22,714$8.0522,714(D)

View →

Jun 24, 2026Jun 26 8:22 PMBriggs MorrisonDirector
Grant/Award
22,714$8.0522,714(D)

View →

Jun 24, 2026Jun 26 8:22 PMEdward Moore Kennedy Jr.Director
Grant/Award
22,714$8.0522,714(D)

View →

Jun 24, 2026Jun 26 8:21 PMEverett CunninghamDirector
Grant/Award
22,714$8.0522,714(D)

View →

Jun 24, 2026Jun 26 8:21 PMLinda BainDirector
Grant/Award
22,714$8.0522,714(D)

View →

Feb 26, 2026Mar 3 2:01 AMDavid K LoomisVP, Chief Accounting Officer
Grant/Award
18,504$13.3818,504(D)

View →

Feb 26, 2026Mar 3 2:00 AMAngela M CacaceChief Scientific Officer
Grant/Award
67,000$13.3867,000(D)

View →

Feb 26, 2026Mar 3 1:59 AMBerkowitz NoahChief Medical Officer
Grant/Award
67,000$13.3867,000(D)

View →

Feb 26, 2026Mar 3 1:58 AMAndrew SaikChief Financial Officer
Grant/Award
67,000$13.3867,000(D)

View →

Feb 26, 2026Mar 3 1:58 AMRandy TeelDirector, President and CEO
Grant/Award
218,691$13.38218,691(D)

View →